Quarterly ResultJun 10, 2026, 08:46 AM
Prenetics Q1 Revenue $36M; IM8 Revenue Up 6x YoY; Guidance Raised
AI Summary
Prenetics Global Ltd reported strong Q1 2026 financial results, driven by its IM8 brand, with total revenue of $36.0 million and IM8 revenue reaching $33.8 million, a nearly 6x increase year-over-year. The company raised its full-year 2026 IM8 revenue guidance to $190 million-$210 million and projected Q2 2026 revenue between $46 million and $48 million. Prenetics also announced the full divestment of its digital asset holdings for $41.3 million and the appointment of Brian J. Rosin as the new CFO for IM8. Despite a reported loss from operations, the company highlighted significant growth in IM8's annualized recurring revenue, which reached approximately $200 million in May 2026.
Key Highlights
- Prenetics Q1 2026 revenue reached $36.0 million, with IM8 revenue at $33.8 million, a 6x year-over-year increase.
- IM8 revenue for May 2026 hit a record ~$16.7 million, implying ~$200 million in annualized recurring revenue.
- Full-year 2026 IM8 revenue guidance raised to $190 million - $210 million.
- Projected Q2 2026 revenue of $46 million to $48 million, with IM8 contributing $44 million to $46 million.
- Company fully divested digital asset holdings for $41.3 million.
- Appointed Brian J. Rosin as Chief Financial Officer of IM8.
- Q1 2026 loss from operations was $8.9 million, with Adjusted EBITDA loss of $5.6 million.
- New SKUs planned for Q4 2026 across Hydration, Creatine, and Kids’ Gummies.
Price Impact
More from PRE